Auna S.A., a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced that it has signed a Memorandum of
Hippocratic AI, a global leader in generative AI healthcare solutions, announced that it has more than doubled its team over the past year and is
Repare Therapeutics Inc. recognized as a clinical-stage precision oncology company, announced that regarding its definitive arrangement agreement with XenoTherapeutics, Inc. and Xeno Acquisition Corp., certain
Scientist.com, recognized as a leading AI driven platform for coordinating R&D activities across the life sciences sector, has officially completed its acquisition by GHO Capital
Most men dislike long conversations about their feelings. This makes discreet support especially valuable in their daily lives. New tech innovations are giving them private
Cancer Check Labs, a leader in multi-cancer early detection, is proud to announce its expansion into New York, furthering its mission to make early detection
MediKarma, the AI-driven platform that unifies and activates patient data to drive proactive care, announced the appointment of two seasoned executives: Dr. Scott Howell as Chief
JardogsHealth, a healthcare innovation company with more than two decades of experience improving clinical operations, announced Springfield Clinic has selected MyMedicalScribe (MMS) as its ambient AI solution
Cantex Continuing Care Network proudly announces the launch of its in-house blood transfusion program, making Cantex the first skilled nursing provider in Texas, and among the
New research reveals that Michigan hospitals are making significant profits off a program designed to help low-income patients access affordable medicine without delivering community benefits.
Klick Health revealed that its teams have been using its InsightFull AI-powered engine to detect and follow data signals that lead to novel insights for its clients’
EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line
